2018
DOI: 10.1016/j.intimp.2018.02.006
|View full text |Cite
|
Sign up to set email alerts
|

IL-17A promotes the formation of deep vein thrombosis in a mouse model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
31
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(32 citation statements)
references
References 32 publications
1
31
0
Order By: Relevance
“…With regard to this cytokine, we emphasize that IL-17 is a pro-inflammatory molecule that activates macrophages, fibroblasts, and stromal cells, including the expression of ICAM-1 and cytokine secretion (IL-6, CXCL-8, IL-11, factor granulocyte colony stimulator [G-CSF]), prostaglandin E2, and nitric oxide) (65-67). Ding et al reported that IL-17A promotes the pathogenesis of deep vein thrombosis (DVT), improving platelet activation and aggregation, neutrophil infiltration, and activation of endothelial cells in murine models (68).…”
Section: Discussionmentioning
confidence: 99%
“…With regard to this cytokine, we emphasize that IL-17 is a pro-inflammatory molecule that activates macrophages, fibroblasts, and stromal cells, including the expression of ICAM-1 and cytokine secretion (IL-6, CXCL-8, IL-11, factor granulocyte colony stimulator [G-CSF]), prostaglandin E2, and nitric oxide) (65-67). Ding et al reported that IL-17A promotes the pathogenesis of deep vein thrombosis (DVT), improving platelet activation and aggregation, neutrophil infiltration, and activation of endothelial cells in murine models (68).…”
Section: Discussionmentioning
confidence: 99%
“…The increasing level of IL-17 could also be related to the hypercoagulation status in patients with coronavirus disease 2019 (COVID-19). 5 Specific IL-17 and SARS-CoV-2 Evidence…”
Section: Possible Role Of Interleukin-17 In Severe Acute Respiratory mentioning
confidence: 99%
“…In contrast, in PV and in ET, the levels of many cytokines or receptors correlated positively with the blood counts of leukocytes, neutrophils and monocytes (IL-1β, IL-1Rα, HGF, MIG), platelets (IL-9, IL-17, SDF-1α) or lymphocytes (IL-9). Of note, recent reports describe IL-9 as a STAT5 activator that enhances megakaryocytopoiesis, and both IL-9 and IL-17 as prothrombotic cytokines [ 58 , 59 , 60 ]. In contrast, the PMF cohort was characterized by negative correlations between numerous cytokines and blood counts of leukocytes, neutrophils and monocytes (TNFα, IL-10, IL-15, VEGF, MIP-1β, IL-8, others) and lymphocytes (IL-17, MIP-1α).…”
Section: Discussionmentioning
confidence: 99%